Cargando…
Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling
BACKGROUND: The renin-angiotensin system (RAS) has been implicated in atherosclerotic lesions and progression to chronic kidney diseases. We examined regulatory roles of angiotensin-converting enzyme 2 (ACE2) in the apolipoprotein E (ApoE) knockout (KO) kidneys. METHODS: The 3-month-old wild-type, A...
Autores principales: | Jin, Hai-Yan, Chen, Lai-Jiang, Zhang, Zhen-Zhou, Xu, Ying-Le, Song, Bei, Xu, Ran, Oudit, Gavin Y, Gao, Ping-Jin, Zhu, Ding-Liang, Zhong, Jiu-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527357/ https://www.ncbi.nlm.nih.gov/pubmed/26245758 http://dx.doi.org/10.1186/s12967-015-0616-8 |
Ejemplares similares
-
Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012) -
Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice
por: Zhang, Zhen-Zhou, et al.
Publicado: (2013) -
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19
por: Oudit, Gavin Y, et al.
Publicado: (2020) -
Angiotensin Converting Enzyme 2 - at the Heart of the COVID-19 pandemic
por: Oudit, Gavin Y., et al.
Publicado: (2023) -
Levels of Angiotensin-Converting Enzyme and Apolipoproteins Are Associated with Alzheimer’s Disease and Cardiovascular Diseases
por: Xu, Chun, et al.
Publicado: (2021)